Clinical Principle Oral cyclosporine A may be offered particularly for patients with Hunner lesions refractory to fulguration and/or triamcinolone
Secondary applications with emerging evidence include wound healing in patients with non-healing tissue, hair follicle stimulation, and early-stage research into cardiac recovery effects following the 2026 human trial data on Thymosin Beta-4
Tetracycline, Doxycycline, and Minocycline Certain vitamins may reduce the ability of tetracycline to treat your infection, according to MedlinePlus
Do not change the dose without consulting your doctor
Moreover, this trial was conducted at a private practice and published in an alternative medicine journal, again raising concerns about bias
Similar blue shift was observed previously when GSH-AuNCs was bound to bulky surfactant (tetraoctylammonium bromide) to rigidify the Au(I)-GSH shell 38